您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(工学版)》

山东大学学报 (工学版) ›› 2025, Vol. 55 ›› Issue (4): 160-172.doi: 10.6040/j.issn.1672-3961.0.2024.297

• 环境工程 • 上一篇    

济南市市民血清中PFASs暴露水平与血压的关联研究

张浩钰1,徐菲2,刘铱3,侯程曦1,丁磊1*   

  1. 1.山东大学环境研究院, 山东 青岛 266237;2.青岛农业大学农学院, 山东 青岛 266109;3.山东大学公共卫生学院, 山东 济南 250012
  • 发布日期:2025-08-31
  • 作者简介:张浩钰(2000— ),女,山西平遥人,硕士研究生,主要研究方向为持久性有机污染物的提取与分析检测. E-mail:zhangzhy678@163.com. *通信作者简介:丁磊(1982— ),男,山东济南人,副教授,硕士生导师,博士,主要研究方向为持久性有机污染物在环境中的分布、迁移规律及其对环境健康的影响. E-mail:Lding@sdu.edu.cn
  • 基金资助:
    国家自然科学基金资助项目(82103948);国家自然科学基金山东联合基金资助项目(U2006214)

Study on associations between serum per- and polyfluoroalkyl substances levels and blood pressure in residents of Jinan

ZHANG Haoyu1, XU Fei2, LIU Yi3, HOU Chengxi1, DING Lei1*   

  1. ZHANG Haoyu1, XU Fei2, LIU Yi3, HOU Chengxi1, DING Lei1*(1. Environment Research Institute, Shandong University, Qingdao 266237, Shandong, China;
    2. College of Agronomy, Qingdao Agricultural University, Qingdao 266109, Shandong, China;
    3. School of Public Health, Shandong University, Jinan 250012, Shandong, China
  • Published:2025-08-31

摘要: 人群暴露于全氟和多氟烷基物质(per- and polyfluoroalkyl substances, PFASs)可能增加高血压发病率。为了评估单体PFAS和PFAS混合物与血压水平和高血压风险之间的关联,使用超高效液相色谱串联轨道肼质谱系统分析了来自中国济南326个空腹血清样本中的18种PFASs。采用多元线性回归模型和逻辑回归模型,分别分析了单体PFAS与收缩压、舒张压及高血压风险之间的关联。为评估PFAS混合物的总体效应,使用了分位数g计算模型和贝叶斯核机器回归模型。所有模型均显示全氟癸酸质量浓度与舒张压正相关,全氟十二酸质量浓度与舒张压负相关,全氟十一酸质量浓度与高血压风险正相关。研究结果表明,随着PFAS混合物质量浓度百分位数增加,研究人群的舒张压和高血压风险均有所升高。

关键词: 全氟和多氟烷基物质, 血压, 联合效应, 贝叶斯核机器回归, 分位数g计算

Abstract: Human was exposed to per- and polyfluoroalkyl substances(PFASs), which were implicated to be associated with elevated prevalence of hypertension. To evaluate the relationships between individual PFAS and PFAS mixture with blood pressure levels and hypertension risk, 18 PFASs in fasting serum samples collected from 326 individuals in Jinan, China were analyzed with an ultrahigh performance liquid chromatography system coupled with an Orbitrap mass spectrometer. Multivariable linear regression and logistic regression models were utilized to analyze the associations between individual PFAS and systolic blood pressure, diastolic blood pressure, and the risk of hypertension, respectively. To evaluate the joint effects of PFAS mixture, quantile g-computation and Bayesian kernel machine regression models were applied. All the models indicated a positive association between perfluorodecanoic acid mass concentration and diastolic blood pressure, a negative association between perfluorododecanoic acid mass concentration and diastolic blood pressure, and a positive association between perfluoroundecanoic acid mass concentration and risk of hypertension. According to a series of results from this study, it was concluded that both diastolic blood pressure and the risk of hypertension increased with the percentile of PFAS mixture mass concentration among the study population.

Key words: PFASs, blood pressure, joint effects, Bayesian kernel machine regression, quantile g-computation

中图分类号: 

  • X828
[1] WILLIAMS B, MANCIA G, SPIERING W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension[J]. European Heart Journal, 2018, 39(33): 3021-3104.
[2] STANAWAY J D, AFSHIN A, GAKIDOU E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2018, 392(10159): 1923-1994.
[3] PAN K, XU J, LONG X P, et al. The relationship between perfluoroalkyl substances and hypertension: a systematic review and meta-analysis[J]. Environmental Research, 2023, 232: 116362.
[4] MILLS K T, STEFANESCU A, HE J. The global epidemiology of hypertension[J]. Nature Reviews Nephrology, 2020, 16(4): 223-237.
[5] WHO. Hypertension[R]. New York, USA: World Health Organization, 2023.
[6] FARDET A, AUBRUN K, ROCK E. Nutrition transition and chronic diseases in China(1990-2019): industrially processed and animal calories rather than nutrients and total calories as potential determinants of the health impact[J]. Public Health Nutrition, 2021, 24(16): 5561-5575.
[7] HAVERINEN E, FERNANDEZ M F, MUSTIELES V, et al. Metabolic syndrome and endocrine disrupting chemicals: an overview of exposure and health effects[J]. International Journal of Environmental Research and Public Health, 2021, 18(24): 13047.
[8] YANG B Y, GUO Y M, BLOOM M S, et al. Ambient PM1 air pollution, blood pressure, and hypertension: insights from the 33 Communities Chinese Health Study[J]. Environmental Research, 2019, 170: 252-259.
[9] XIAO F, AN Z, LV J, et al. Association between per- and polyfluoroalkyl substances and risk of hypertension: a systematic review and meta-analysis[J]. Frontiers in Public Health, 2023, 11: 1173101.
[10] LI Y, LI D, CHEN J Q, et al. Presence of organophosphate esters in plasma of patients with hypertension in Hubei Province, China[J]. Environmental Science and Pollution Research, 2020, 27(19): 24059-24069.
[11] HU L, YU M, LI Y, et al. Association of exposure to organophosphate esters with increased blood pressure in children and adolescents[J]. Environmental Pollution, 2022, 295: 118685.
[12] GUO X W, KE Y J, WU B R, et al. Exploratory analysis of the association between organophosphate ester mixtures with high blood pressure of children and adolescents aged 8-17 years: cross-sectional findings from the National Health and Nutrition Examination Survey[J]. Environmental Science and Pollution Research, 2023, 30(9): 22900-22912.
[13] JIANG S, LIU H, ZHOU S, et al. Association of bisphenol A and its alternatives bisphenol S and F exposure with hypertension and blood pressure: a cross-sectional study in China[J]. Environmental Pollution, 2020, 257: 113639.
[14] JIANG S, YANG G, ZHOU S, et al. Bisphenol A, S, and F exposure, ESR1/2, CAT, and eNOS genetic polymorphisms, and the risk of hypertension[J]. Ecotoxicology and Environmental Safety, 2021, 224: 112684.
[15] EVICH M G, DAVIS M J B, MCCORD J P, et al. Per- and polyfluoroalkyl substances in the environment[J]. Science, 2022, 375(6580): eabg9065.
[16] BERHANU A, MUTANDA I, JI T L, et al. A review of microbial degradation of per- and polyfluoroalkyl substances(PFAS): biotransformation routes and enzymes[J]. Science of the Total Environment, 2023, 859: 160010.
[17] BRUSSEAU M L, ANDERSON R H, GUO B. PFAS concentrations in soils: background levels versus contaminated sites[J]. Science of the Total Environment, 2020, 740: 140017.
[18] COUSINS I T, JOHANSSON J H, SALTER M E, et al. Outside the safe operating space of a new planetary boundary for per- and polyfluoroalkyl substances(PFAS)[J]. Environmental Science & Technology, 2022, 56(16): 11172-11179.
[19] XU B, LIU S, ZHOU J L, et al. PFAS and their substitutes in groundwater: occurrence, transformation and remediation[J]. Journal of Hazardous Materials, 2021, 412: 125159.
[20] WANG Q, RUAN Y, LIN H, et al. Review on perfluoroalkyl and polyfluoroalkyl substances(PFASs)in the Chinese atmospheric environment[J]. Science of the Total Environment, 2020, 737: 139804.
[21] FENG X, YE M, LI Y, et al. Potential sources and sediment-pore water partitioning behaviors of emerging per/polyfluoroalkyl substances in the South Yellow Sea[J]. Journal of Hazardous Materials, 2020, 389: 122124.
[22] COUSINS I T, DEWITT J C, GLÜGE J, et al. The high persistence of PFAS is sufficient for their management as a chemical class[J]. Environmental Science: Processes & Impacts, 2020, 22(12): 2307-2312.
[23] COMITO R, PORRU E, VIOLANTE F S. Analytical methods employed in the identification and quantification of per- and polyfluoroalkyl substances in human matrices-a scoping review[J]. Chemosphere, 2023, 345: 140433.
[24] POOTHONG S, PAPADOPOULOU E, PADILLA-SÁNCHEZ J A, et al. Multiple pathways of human exposure to poly- and perfluoroalkyl substances(PFASs): from external exposure to human blood[J]. Environment International, 2020, 134: 105244.
[25] CHOW S J, OJEDA N, JACANGELO J G, et al. Detection of ultrashort-chain and other per- and polyfluoroalkyl substances(PFAS)in U.S. bottled water[J]. Water Research, 2021, 201: 117292.
[26] LIANG L, PAN Y, BIN L, et al. Immunotoxicity mechanisms of perfluorinated compounds PFOA and PFOS[J]. Chemosphere, 2022, 291: 132892.
[27] LI Z, LIN Z, JI S, et al. Perfluorooctanesulfonic acid exposure altered hypothalamic metabolism and disturbed male fecundity[J]. Science of the Total Environment, 2022, 844: 156881.
[28] WU L, DANG Y, LIANG L X, et al. Perfluorooctane sulfonates induces neurobehavioral changes and increases dopamine neurotransmitter levels in zebrafish larvae[J]. Chemosphere, 2022, 297: 134234.
[29] FENG X, LONG G, ZENG G, et al. Association of increased risk of cardiovascular diseases with higher levels of perfluoroalkylated substances in the serum of adults[J]. Environmental Science and Pollution Research, 2022, 29(59): 89081-89092.
[30] PITTER G, ZARE JEDDI M, BARBIERI G, et al. Perfluoroalkyl substances are associated with elevated blood pressure and hypertension in highly exposed young adults[J]. Environmental Health, 2020, 19(1): 102.
[31] YAO X, ZHONG L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid[J]. Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 2005, 587(1): 38-44.
[32] LIAO S, YAO W, CHEANG I, et al. Association between perfluoroalkyl acids and the prevalence of hypertension among US adults[J]. Ecotoxicology and Environmental Safety, 2020, 196: 110589.
[33] WIELSØE M, LONG M, GHISARI M, et al. Perfluoroalkylated substances(PFAS)affect oxidative stress biomarkers in vitro[J]. Chemosphere, 2015, 129: 239-245.
[34] KONUKOGLU D, UZUN H. Endothelial dysfunction and hypertension[J]. Advances in Experimental Medicine and Biology, 2017, 956: 511-540.
[35] RAZVI S, JABBAR A, PINGITORE A, et al. Thyroid hormones and cardiovascular function and diseases[J]. Journal of the American College of Cardiology, 2018, 71(16): 1781-1796.
[36] DONAT-VARGAS C, BERGDAHL I A, TORNEVI A, et al. Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors[J]. Environment International, 2019, 124: 58-65.
[37] GUZIK T J, TOUYZ R M. Oxidative stress, inflammation, and vascular aging in hypertension[J]. Hypertension, 2017, 70(4): 660-667.
[38] BAO W W, QIAN Z, GEIGER S D, et al. Gender-specific associations between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: isomers of C8 Health Project in China[J]. Science of the Total Environment, 2017, 607: 1304-1312.
[39] MI X, YANG Y Q, ZEESHAN M, et al. Serum levels of per- and polyfluoroalkyl substances alternatives and blood pressure by sex status: isomers of C8 Health Project in China[J]. Chemosphere, 2020, 261: 127691.
[40] UNEP. Listing of perfluorooctane sulfonic acid, its salts, and perfluorooctane sulfonyl fluoride[R]. Geneva, Switzerland: United Nations Environment Program-me, 2009.
[41] UNEP. Listing of perfluorooctanoic acid(PFOA), its salts and PFOA-related compounds[R]. Geneva, Switzerland: United Nations Environment Programme, 2019.
[42] UNEP. Report of the conference of the parties to the stockholm convention on persistent organic pollutants on the work of its tenth meeting[R]. Geneva, Switzerland: United Nations Environment Programme, 2022.
[43] BRENDEL S, FETTER É, STAUDE C, et al. Short-chain perfluoroalkyl acids: environmental concerns and a regulatory strategy under REACH[J]. Environmental Sciences Europe, 2018, 30: 9.
[44] LI Y, FENG X, ZHOU J, et al. Occurrence and source apportionment of novel and legacy poly/perfluoroalkyl substances in Hai River basin in China using receptor models and isomeric fingerprints[J]. Water Research, 2020, 168: 115145.
[45] LIANG X, ZHOU J, YANG X, et al. Disclosing the bioaccumulation and biomagnification behaviors of emerging per/polyfluoroalkyl substances in aquatic food web based on field investigation and model simulation[J]. Journal of Hazardous Materials, 2023, 445: 130566.
[46] BRASE R A, MULLIN E J, SPINK D C. Legacy and emerging per- and polyfluoroalkyl substances: analytical techniques, environmental fate, and health effects[J]. International Journal of Molecular Sciences, 2021, 22(3): 995.
[47] LEE J W, LEE H K, LIM J E, et al. Legacy and emerging per- and polyfluoroalkyl substances(PFASs)in the coastal environment of Korea: occurrence, spatial distribution, and bioaccumulation potential[J]. Chemosphere, 2020, 251: 126633.
[48] WANG Y, LI X T, ZHENG Z, et al. Chlorinated polyfluoroalkyl ether sulfonic acids in fish, dust, drinking water and human serum: from external exposure to internal doses[J]. Environment International, 2021, 157: 106820.
[49] DENG M, WU Y, XU C, et al. Multiple approaches to assess the effects of F-53B, a Chinese PFOS alternative, on thyroid endocrine disruption at environmentally relevant concentrations[J]. Science of the Total Environment, 2018, 624: 215-224.
[50] HE Y X, LV D, LI C H, et al. Human exposure to F-53B in China and the evaluation of its potential toxicity: an overview[J]. Environment International, 2022, 161: 107108.
[51] SHI Y, VESTERGREN R, XU L, et al. Human exposure and elimination kinetics of chlorinated polyfluoroalkyl ether sulfonic acids(Cl-PFESAs)[J]. Environmental Science & Technology, 2016, 50(5): 2396-2404.
[52] AVERINA M, BROX J, HUBER S, et al. Exposure to perfluoroalkyl substances(PFAS)and dyslipidemia, hypertension and obesity in adolescents. The Fit Futures study[J]. Environmental Research, 2021, 195: 110740.
[53] ZHANG Z F, WANG F, ZHANG Y, et al. Associations of serum PFOA and PFOS levels with incident hypertension risk and change of blood pressure levels[J]. Environmental Research, 2022, 212: 113293.
[54] ZHANG Y T, ZEESHAN M, SU F, et al. Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: the isomers of C8 health project in China[J]. Environment International, 2022, 158: 106913.
[55] XING Y A, LI Z, WANG J H, et al. Associations between serum per- and polyfluoroalkyl substances and thyroid hormones in Chinese adults: a nationally representative cross-sectional study[J]. Environment International, 2024, 184: 108459.
[56] YAN W, BAI R, ZHENG Q, et al. Concentrations and association between exposure to mixed perfluoroalkyl and polyfluoroalkyl substances and glycometabolism among adolescents[J]. Annals of Medicine, 2023, 55(1): 2227844.
[57] FAN Y, LI X, XU Q, et al. Serum albumin mediates the effect of multiple per- and polyfluoroalkyl substances on serum lipid levels[J]. Environmental Pollution, 2020, 266: 115138.
[58] BOAFO Y S, MOSTAFA S, OBENG-GYASI E. Association of combined metals and PFAS with cardiovascular disease risk[J]. Toxics, 2023, 11(12): 979.
[59] DING N, KARVONEN-GUTIERREZ C A, MUKHERJEE B, et al. Per- and polyfluoroalkyl substances and incident hypertension in multi-racial/ethnic women: the study of women's health across the nation[J]. Hypertension, 2022, 79(8): 1876-1886.
[60] MUNTNER P, MILES M A, JAEGER B C, et al. Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020[J]. Hypertension, 2022, 79(9): 1971-1980.
[61] LIU Y, ZHANG H, XU F, et al. Associations between serum per- and polyfluoroalkyl substances as mixtures and lipid levels: a cross-sectional study in Jinan[J]. The Science of the Total Environment, 2024, 923: 171305.
[62] ZENG Y, GOUDARZI H, AIT BAMAI Y, et al. Exposure to organophosphate flame retardants and plasticizers is positively associated with wheeze and FeNO and eosinophil levels among school-aged children: the Hokkaido study[J]. Environment International, 2023, 181: 108278.
[63] ZHAO S, FAN L, WANG Y, et al. Combined exposure to multiple metals on hypertension in NHANES under four statistical models[J]. Environmental Science and Pollution Research, 2023, 30(40): 92937-92949.
[64] ZHANG X, ZHANG Y, LU H, et al. Environmental exposure to paraben and its association with blood pressure: a cross-sectional study in China[J]. Chemosphere, 2023, 339: 139656.
[65] BOBB J F, VALERI L, CLAUS HENN B, et al. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures[J]. Biostatistics, 2015, 16(3): 493-508.
[66] BOBB J F, CLAUS HENN B, VALERI L, et al. Statistical software for analyzing the health effects of multiple concurrent exposures via Bayesian kernel machine regression[J]. Environmental Health, 2018, 17(1): 67.
[67] KEIL A P, BUCKLEY J P, O'BRIEN K M, et al. A quantile-based g-computation approach to addressing the effects of exposure mixtures[J]. Environmental Health Perspectives, 2020, 128(4): 47004.
[68] CHEN Y R, LV J Y, FU L, et al. Metabolome-wide association study of four groups of persistent organic pollutants and abnormal blood lipids[J]. Environment International, 2023, 173: 107817.
[69] DUAN Y, SUN H, YAO Y, et al. Distribution of novel and legacy per-/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among Chinese adult men and women with normal blood glucose levels[J]. Environment International, 2020, 134: 105295.
[70] JIN H, LIN S, DAI W, et al. Exposure sources of perfluoroalkyl acids and influence of age and gender on concentrations of chlorinated polyfluorinated ether sulfonates in human serum from China[J]. Environment International, 2020, 138: 105651.
[71] LIU X, LUO K, ZHANG J, et al. Exposure of preconception couples to legacy and emerging per-and polyfluoroalkyl substances: variations within and between couples[J]. Environmental Science & Technology, 2022, 56(10): 6172-6181.
[72] YANG Z, LIU R, LIU H, et al. Sex-specific effect of perfluoroalkyl substances exposure on liver and thyroid function biomarkers: a mixture approach[J]. International Journal of Hygiene and Environmental Health, 2023, 251: 114189.
[73] JIA X, JIN Q, FANG J, et al. Emerging and legacy per- and polyfluoroalkyl substances in an elderly population in Jinan, China: the exposure level, short-term variation, and intake assessment[J]. Environmental Science & Technology, 2022, 56(12): 7905-7916.
[74] SCHULZ K, SILVA M R, KLAPER R. Distribution and effects of branched versus linear isomers of PFOA, PFOS, and PFHxS: a review of recent literature[J]. Science of the Total Environment, 2020, 733: 139186.
[75] ZEESHAN M, YANG Y Q, ZHOU Y, et al. Incidence of ocular conditions associated with perfluoroalkyl substances exposure: isomers of C8 Health Project in China[J]. Environment International, 2020, 137: 105555.
[76] LIN P I D, CARDENAS A, HAUSER R, et al. Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults—cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study[J]. Environment International, 2020, 137: 105573.
[77] TOUYZ R M, RIOS F J, ALVES-LOPES R, et al. Oxidative stress: a unifying paradigm in hypertension[J]. Canadian Journal of Cardiology, 2020, 36(5): 659-670.
[78] LIU S Y, WANG Q, ZHOU H, et al. Adrenomedullin improved endothelial dysfunction via receptor-Akt pathway in rats with obesity-related hypertension[J]. Hypertension Research, 2024, 47(8): 2157-2171.
[79] KANG J S, CHOI J S, PARK J W. Transcriptional changes in steroidogenesis by perfluoroalkyl acids(PFOA and PFOS)regulate the synthesis of sex hormones in H295R cells[J]. Chemosphere, 2016, 155: 436-443.
[1] 方昕鑫,张仕文,朱雨婷,姜威,张肇元,赵楠. 济南市食品中短、中链氯化石蜡的污染特征及摄入风险评估[J]. 山东大学学报 (工学版), 2021, 51(3): 119-128.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!